Advokatfirman Lindahl advises Stille on a directed share issue of SEK 425 million in conjunction with Stille’s acquisition of Fehling
Lindahl has acted as advisor in connection with Stille AB (publ)'s directed share issue of approximately SEK 425 million. The proceeds are intended to be used to finance the acquisition of Fehling.
Fehling is a family-owned German company that develops and sells high-quality medical instruments. Fehling has a strong market position with direct operations in Germany, Switzerland, the US, Singapore, the United Arab Emirates and Malaysia.
Stille develops, manufactures and markets medical devices for specialist surgeons worldwide. Stille is one of the world's oldest medical technology companies, with a focus on surgical instruments and operating tables. The company has a stable base with a strong brand and well-known products of recognized high quality.
Pareto Securities AB has acted as Sole Manager and Bookrunner.
Lindahl's team mainly consisted of Ola Svanberg, Victoria Skoglund, Gustav Ahlgren, Jakob Josefsson and Ebba Meyer-Lie.
Do you want to know more? Contact:
Ola Svanberg
Partner | AdvokatVictoria Skoglund
Partner | AdvokatJakob Poulidas Josefsson
AssociateEbba Meyer-Lie
AssociateCarousel items
-
Cases and transactions
5/14/2025
Lindahl advises Heba in connection with buyback program
Lindahl advises Heba Fastighets AB in connection with the company’s repurchase of its own series B shares.
-
Knowledge
4/30/2025
New rules on review and damages for violations of EU law provisions
The government has decided on a bill proposing amendments to the procurement legislation. Among other things, it is proposed that suppliers' rights to legal remedies, in the form of review and damages, be clarified in the procurement laws concerni...
-
News articles
4/11/2025
Lindahl awarded at the Managing IP Awards
Lindahl has been named the winner in the category Sweden Trademark Prosecution (Law Firms) at the Managing IP EMEA Awards 2025.
-
Read more news and insights?
